Work

Clinical Activity of the Immunoconjugate CMC-544 in B-Cell Malignancies: Preliminary Report of the Expanded Maximum Tolerated Dose (MTD) Cohort of a Phase 1 Study.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2711.2711

Authors: Luis Fayad, Hemant Patel, Gregor Verhoef, Myron Czuczman, James Foran, Eva Gine, Ama Rohatiner, Mitchell R. Smith, Mark Shapiro, Anjali Advani

Institutions: The University of Texas MD Anderson Cancer Center, Wyeth, Universitair Ziekenhuis Leuven, Roswell Park Comprehensive Cancer Center, University of Alabama at Birmingham, Hospital Clínic de Barcelona, St Bartholomew's Hospital, Fox Chase Cancer Center, Cleveland Clinic

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2565484423

FWCI: 3.711

Cites:

Cited by: 30

Related to: 10